This post will be a little different from most of the expert posts on GRACE. I’m not an expert. I’m not an oncologist. In fact, I’m not a physician. I’m a patient with a social science background, and I’ve followed the work on the drug I’m writing about for some time. I’ve been interested in Zactima (vandetanib) for two reasons. First, I thought the early trials looked promising, and it might eventually be a drug that could help me. Second (and this is going to drive Dr. West crazy), the four large phase III trials of Zactima have really catchy acronyms (see below).
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock
Comments
test test test
test
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam id sapien quis lorem sollicitudin